Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder

In this case series, risperidone augmentation of treatment with a serotonin reuptake inhibitor (SRI) is described in four pediatric patients diagnosed with obsessive compulsive disorder (OCD), An improved treatment response was observed in all cases, albeit in different ways, All four of the patients had failed prior SRI monotherapy. Comorbid ties were observed in two cases and aggressive behavior or violent images were seen in three. Possible predictors of response to risperidone in patients with OCD and future research avenues are explored.